Perspective Therapeutics, Inc. (CATX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 1M 2M 3M Q3 '16: 1.1M Q4 '16: 1M Q1 '17: 1.3M Q2 '17: 1.4M Q3 '17: 1.2M Q4 '17: 1.5M Q1 '18: 1.6M Q2 '18: 1.6M Q3 '18: 1.6M Q4 '18: 1.9M Q1 '19: 1.9M Q2 '19: 1.9M Q3 '19: 2.3M Q4 '19: 2.2M Q1 '20: 2.9M Q2 '20: 2.3M Q3 '20: 2.4M Q4 '20: 2.4M Q1 '21: 2.6M Q2 '21: 2.7M Q3 '21: 2.6M Q4 '21: 2.8M Q1 '22: 0 Q2 '22: 0 Q3 '22: 0 Q4 '22: 0 Q1 '23: 233K Q2 '23: 588K Q3 '23: 276K Q4 '23: 337K Q1 '24: 325K Q2 '24: 526K Q3 '24: 369K Q4 '24: 234K Q1 '25: 342K Q2 '25: 290K Q3 '25: 209K Q4 '25: 43K Q1 '26: 76K Q2 '26: 81K Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit Quarterly

-600K 0 600K 1.2M 1.8M Q1 '14: 50.9K Q2 '14: -136.2K Q3 '14: -54.8K Q4 '14: -38K Q1 '15: 55.2K Q2 '15: 205K Q3 '15: 83K Q4 '15: 27K Q1 '16: 67K Q2 '16: -48K Q3 '16: 48K Q4 '16: -1K Q1 '17: 293K Q2 '17: 498K Q3 '17: 265K Q4 '17: 531K Q1 '18: 609K Q2 '18: 443K Q3 '18: 524K Q4 '18: 765K Q1 '19: 879K Q2 '19: 879K Q3 '19: 1.2M Q4 '19: 1.1M Q1 '20: 1.7M Q2 '20: 1.1M Q3 '20: 1.2M Q4 '20: 1.2M Q1 '21: 1.4M Q2 '21: 1.3M Q3 '21: 1M Q4 '21: 1.2M Q1 '22: 1.4M Q2 '22: 926K Q3 '22: 414K Q4 '22: -414K Q1 '23: 487K Q2 '23: 248K Q3 '23: 738K Q4 '23: -39K Q1 '15 Q2 '16 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23

Operating Income Quarterly

-60M -40M -20M 0 20M 40M 60M Q3 '16: -1.6M Q4 '16: -1.5M Q1 '17: -1.4M Q2 '17: -1.9M Q3 '17: -1.6M Q4 '17: -1.5M Q1 '18: -1.3M Q2 '18: -2.4M Q3 '18: -1.5M Q4 '18: -1.4M Q1 '19: -1.2M Q2 '19: -1.1M Q3 '19: -836K Q4 '19: -903K Q1 '20: -548K Q2 '20: -1.2M Q3 '20: -714K Q4 '20: -873K Q1 '21: -766K Q2 '21: -1.1M Q3 '21: -2.3M Q4 '21: -1.6M Q1 '22: -1.4M Q2 '22: -2.1M Q3 '22: -4.2M Q4 '22: -1.4M Q1 '23: -9.8M Q2 '23: -9.8M Q3 '23: -9.8M Q4 '23: -11.7M Q1 '24: -13M Q2 '24: -14.3M Q3 '24: -18.6M Q4 '24: -45M Q1 '25: -21.8M Q2 '25: -24M Q3 '25: -27.9M Q4 '25: -39.8M Q1 '26: -28.3M Q2 '26: -29.3M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income Quarterly

-45M -30M -15M 0 15M 30M 45M Q3 '16: -1.5M Q4 '16: -1.4M Q1 '17: -1.4M Q2 '17: -1.9M Q3 '17: -1.5M Q4 '17: -1.5M Q1 '18: -1.3M Q2 '18: -2.3M Q3 '18: -1.5M Q4 '18: -1.4M Q1 '19: -1.1M Q2 '19: -1.1M Q3 '19: -816K Q4 '19: -897K Q1 '20: -545K Q2 '20: -1.2M Q3 '20: -713K Q4 '20: -868K Q1 '21: -745K Q2 '21: -1.1M Q3 '21: -2.2M Q4 '21: -1.6M Q1 '22: -1.3M Q2 '22: -2.1M Q3 '22: -4.1M Q4 '22: -3.3M Q1 '23: -371K Q2 '23: -11.1M Q3 '23: -10.4M Q4 '23: -24.7M Q1 '24: -12.3M Q2 '24: -11.7M Q3 '24: -15.1M Q4 '24: -40.2M Q1 '25: -18.2M Q2 '25: -21.5M Q3 '25: -26M Q4 '25: -37.5M Q1 '26: -26.2M Q2 '26: -26.8M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue Quarterly

0 700K 1.4M 2.1M Q1 '17: 989K Q2 '17: 872K Q3 '17: 946K Q4 '17: 1M Q1 '18: 964K Q2 '18: 1.2M Q3 '18: 1M Q4 '18: 1.1M Q1 '19: 1M Q2 '19: 1M Q3 '19: 1.1M Q4 '19: 1.1M Q1 '20: 1.2M Q2 '20: 1.2M Q3 '20: 1.1M Q4 '20: 1.2M Q1 '21: 1.2M Q2 '21: 1.4M Q3 '21: 1.5M Q4 '21: 1.6M Q1 '22: 1.5M Q2 '22: 1.6M Q3 '22: 1.3M Q4 '22: 1.4M Q1 '23: 1.6M Q2 '23: 1.8M Q3 '23: 1.4M Q3 '17 Q3 '18 Q3 '19 Q3 '20 Q3 '21 Q3 '22 Q3 '23

Operating Cash Flow Quarterly

-45M -30M -15M 0 15M 30M 45M Q3 '16: -1.4M Q4 '16: -1.7M Q1 '17: -1.5M Q2 '17: -1.2M Q3 '17: -1.7M Q4 '17: -1.5M Q1 '18: -1.1M Q2 '18: -1.4M Q3 '18: -1.6M Q4 '18: -1.1M Q1 '19: -1.3M Q2 '19: -985K Q3 '19: -653K Q4 '19: -1.3M Q1 '20: -862K Q2 '20: -848K Q3 '20: -338K Q4 '20: -760K Q1 '21: -621K Q2 '21: -1.1M Q3 '21: -2.1M Q4 '21: -1.3M Q1 '22: -1.4M Q2 '22: -2.9M Q3 '22: -1.8M Q4 '22: -4.3M Q1 '23: -9.7M Q2 '23: -8.1M Q3 '23: -10.1M Q4 '23: -9M Q1 '24: 13.8M Q2 '24: -8.9M Q3 '24: 3.4M Q4 '24: -26.6M Q1 '25: -21.6M Q2 '25: -20M Q3 '25: -16.3M Q4 '25: -24.7M Q1 '26: -31.5M Q2 '26: -20.6M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow Quarterly

-45M -30M -15M 0 15M 30M 45M Q3 '16: -1.5M Q4 '16: -1.8M Q1 '17: -1.5M Q2 '17: -1.5M Q3 '17: -1.7M Q4 '17: -1.6M Q1 '18: -1.2M Q2 '18: -1.6M Q3 '18: -1.7M Q4 '18: -1.2M Q1 '19: -1.5M Q2 '19: -1.1M Q3 '19: -751K Q4 '19: -1.4M Q1 '20: -906K Q2 '20: -873K Q3 '20: -451K Q4 '20: -820K Q1 '21: -714K Q2 '21: -1.2M Q3 '21: -2.1M Q4 '21: -1.4M Q1 '22: -1.4M Q2 '22: -3M Q3 '22: -1.9M Q4 '22: -4.4M Q1 '23: -9.9M Q2 '23: -8.6M Q3 '23: -10.3M Q4 '23: -9.1M Q1 '24: 4.8M Q2 '24: -9.9M Q3 '24: -26.3M Q4 '24: -41.2M Q1 '25: -26.2M Q2 '25: -21M Q3 '25: -18.3M Q4 '25: -29.7M Q1 '26: -38.3M Q2 '26: -34.8M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 80M 160M 240M Q3 '20: 68.9M Q4 '20: 83M Q1 '21: 122.6M Q2 '21: 141.7M Q3 '21: 141.9M Q4 '21: 142M Q1 '22: 142M Q2 '22: 142M Q3 '22: 142.1M Q1 '23: 228.6M Q2 '23: 28M Q3 '23: 28.1M Q1 '24: 49.5M Q2 '24: 66.6M Q3 '24: 70.6M Q1 '25: 72.4M Q2 '25: 74.2M Q3 '25: 74.3M Q1 '26: 103.6M Q2 '26: 120.7M Q4 '20 Q3 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-2.10 -1.40 -0.70 0.00 0.70 1.40 2.10 Q3 '16: -0.09 Q4 '16: -0.10 Q1 '17: -0.10 Q2 '17: -0.11 Q3 '17: -0.11 Q4 '17: -0.11 Q1 '18: -0.11 Q2 '18: -0.12 Q3 '18: -0.11 Q4 '18: -0.10 Q1 '19: -0.10 Q2 '19: -0.08 Q3 '19: -0.07 Q4 '19: -0.06 Q1 '20: -0.05 Q2 '20: -0.05 Q3 '20: -0.05 Q4 '20: -0.05 Q1 '21: -0.05 Q2 '21: -0.04 Q3 '21: -0.05 Q4 '21: -0.05 Q1 '22: -0.05 Q2 '22: -0.05 Q3 '22: -0.06 Q4 '22: -0.07 Q1 '23: -0.06 Q2 '23: -0.45 Q3 '23: -0.79 Q4 '23: -1.68 Q1 '24: -1.93 Q2 '24: -1.71 Q3 '24: -1.55 Q4 '24: -1.25 Q1 '25: -1.25 Q2 '25: -1.36 Q3 '25: -1.50 Q4 '25: -1.40 Q1 '26: -1.40 Q2 '26: -1.33 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.